Methods of preventing bacterial sepsis and wound complications for liver transplantation

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2008, Pages

  Gurusamy, Kurinchi Selvan ^a   Kumar, Yogesh ^b   Davidson, Brian R ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; AMPICILLIN; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; AZATHIOPRINE; CEFOTAXIME; CEFTRIAXONE; COLISTIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GENTAMICIN; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENT; METRONIDAZOLE; NYSTATIN; PLACEBO; POLYMYXIN; PREBIOTIC AGENT; PROBIOTIC AGENT; STEROID; TACROLIMUS; TOBRAMYCIN;

ABDOMINAL CRAMP; ABDOMINAL INFECTION; BACTEREMIA; CATHETER INFECTION; CHEST INFECTION; CHOLANGITIS; CLINICAL TRIAL; COCHRANE LIBRARY; CONTROL GROUP; DIARRHEA; DISEASE CONTROL; EMBASE; ENTERIC FEEDING; GRAFT REJECTION; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE SEPSIS; HEMATOMA; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFORMATION PROCESSING; INTENSIVE CARE UNIT; INTRAVASCULAR CATHETER; LACTOBACILLUS; LIVER TRANSPLANTATION; MEDLINE; META ANALYSIS; MORBIDITY; MORTALITY; NUTRITION; PREVENTIVE HEALTH SERVICE; RANDOM SAMPLE; RETRANSPLANTATION; REVIEW; RISK BENEFIT ANALYSIS; SCISEARCH; SEPSIS; SEPTICEMIA; SEROMA; SYSTEMATIC REVIEW; URINARY TRACT INFECTION; WASTE MANAGEMENT; WOUND COMPLICATION; WOUND DEHISCENCE; WOUND INFECTION;

EID: 55049107040     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006660.pub2     Document Type: Review

References (54)

1. Arnow 1996 {published data only} Arnow PM, Carandang GC, Zabner R, Irwin ME. Randomized controlled trial of selective bowel decontamination for prevention of infections following liver transplantation. Clinical Infectious Diseases 1996;22(6):997-1003.
2. Bion 1994 {published data only} Badger IL, Crosby HA, Kong KL, Baker JP, Hutchings P, Elliott TS, et al.Is selective decontamination of the digestive tract beneficial in liver transplant patients? Interim results of a prospective, randomized trial. Transplantation Proceedings 1991;23(1 Part 2):1460-1.
3. * Bion JF, Badger I, Crosby HA, Hutchings P, Kong KL, Baker J, et al.Selective decontamination of the digestive tract reduces gram-negative pulmonary colonization but not systemic endotoxemia in patients undergoing elective liver transplantation. Critical Care Medicine 1994;22(1):40-9.
4. Hellinger 2002 {published and unpublished data} Hellinger WC, Yao JD, Alvarez S, Blair JE, Cawley JJ, Paya CV, et al.A randomized, prospective, double-blinded evaluation of selective bowel decontamination in. Transplantation 2002;73(12):1904-9.
5. Rayes 2002 {published and unpublished data} * Rayes N, Brammer M, Hansen S, Mueller AR, Serke S, Seehofer D, et al.Early interal supply of lactobacilli and fiber versus SBD - A prospective randomized trial in liver transplant recipients (abstract). Journal of Hepatology 2001;34(1):199.
6. Rayes N, Seehofer D, Hansen S, Boucsein K, Muller AR, Serke S, et al.Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation 2002;74(1):123-7.
7. Rayes N, Seehofer D, Muller AR, Hansen S, Bengmark S, Neuhaus P. Influence of probiotics and fibre on the incidence of bacterial infections following major abdominal surgery - results of a prospective trial. Zeitschrift für Gastroenterologie 2002;40(10):869-76.
8. Rayes 2005 {published and unpublished data} Rayes N, Seehofer D, Theruvath T, Schiller RA, Langrehr JM, Jonas S, et al.Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation - a randomized, double-blind trial. American Journal of Transplantation 2005;5(1):125-30.
9. Winston 1999 {published data only} Winston DJ, Foster PF, Somberg KA, Busuttil RW, Levy MF, Sheiner PA, et al.Randomized, placebo-controlled, double-blind, multicenter trial of efficacy and safety of granulocyte colony-stimulating factor in liver transplant recipients. Transplantation 1999;68(9):1298-304.
10. Zwaveling 2002 {published data only} Maring JK, Zwaveling JH, Klompmaker IJ, van der Meer J, Slooff MJ. Selective bowel decontamination in elective liver transplantation: no improvement in endotoxaemia, initial graft function and postoperative morbidity. Transplant International 2002;15(7):329-34.
11. van Enckevort PJ, Zwaveling JH, Bottema JT, Maring JK, Klompmaker IJ, Slooff MJH, et al.Cost effectiveness of selective decontamination of the digestive tract in liver transplant patients. Pharmacoeconomics 2001;19(5):523-30.
12. * Zwaveling JH, Maring JK, Klompmaker IJ, Haagsma EB, Bottema JT, Laseur M, et al.Selective decontamination of the digestive tract to prevent postoperative infection: a randomized placebo-controlled trial in liver transplant patients. Critical Care Medicine 2002;30(6): 1204-9.
13. Biasi 2002 {published data only} Biasi F, Poli G, Salizzoni M, Cerutti E, Battista S, Mengozzi G, et al.Effect of perioperative infusion of antioxidants on neutrophil activation during liver transplantation in humans. Transplantation Proceedings 2002;34(3):755-8.
14. Cisneros 1993 {published data only} Cisneros AC, Sanchez IRJA, Montejo GJC, Arribas LP, Martinez DLGA. Infections in the post-surgical period of liver transplantation. Comparison of two protocols with anti-infective prophylaxis. Revista Clinica Espanola 1993;192(3):112-5.
15. Decruyenaere 1995 {published data only} Decruyenaere J, Colardyn F, Vogelaers D, Claeys G, Hesse U, De Deyne C, et al.Combined use of fluconazole and selective digestive decontamination in the prevention of fungal infection after adult liver transplantation. Transplantation Proceedings 1995;27(6):3515-6.
16. Hasse 1995 {published data only} Hasse JM, Blue LS, Liepa GU, Goldstein RM, Jennings LW, Mor E, et al.Early enteral nutrition support in patients undergoing liver transplantation. Journal of Parenteral and Enteral Nutrition 1995;19 (6):437-43.
17. Ott 2006 {published data only} Ott R, Bussenius-Kammerer M, Reck T, Hering C, Muller V, Riese J, et al.Does the inactivation of leukocytes in blood transfusions during and following liver transplantation by gamma-irradiation have an impact on rejection and infection rate?. Medical Science Monitor 2006;12(12):514-20.
18. Philpott-Howard 2003 {published data only} Philpott-Howard J, Burroughs A, Fisher N, Hastings M, Kibbler C, Mutimer D, et al.Piperacillin-tazobactam versus ciprofloxacin plus amoxicillin in the treatment of infective episodes after liver transplantation. Journal of Antimicrobial Chemotherapy 2003;52(6):993-1000.
19. Smith 1993 {published data only} Smith SD, Jackson RJ, Hannakan CJ, Wadowsky RM, Tzakis AG, Rowe MI. Selective decontamination in pediatric liver transplants. A randomized prospective study. Transplantation 1993;55(6):1306-9.
20. van Saene 2003 {published data only} van Saene HK, Silvestri L, Bams JL, van der Voort PH, Zandstra DF. Selective decontamination of the digestive tract: use in liver transplantation is evidence based. Critical Care Medicine 2003;31(5):1600-1.
21. Blair 2005 Blair JE, Kusne S. Bacterial, mycobacterial, and protozoal infections after liver transplantation - part I. Liver Transplantation 2005;11(12): 1452-9.
22. Bombuy 2004 Bombuy E, Fondevila C, Rodriguez-Laiz G, Ferrer J, Amador A, Valentini M, et al.Ischemic preconditioning in adult living donor liver transplantation, a pilot study [EASL abstract]. Journal of Hepatology 2004;40(Suppl 1):39.
23. Cescon 2006 Cescon M, Grazi GL, Grassi A, Ravaioli M, Vetrone G, Ercolani G, et al.Effect of ischemic preconditioning in whole liver transplantation from deceased donors. A pilot study. Liver Transplantation 2006;12 (4):628-35.
24. Corno 2006 Corno V, Colledan M, Dezza MC, Guizzetti M, Lucianetti A, Maldini G, et al.Extended right split liver graft for primary transplantation in children and adults. Transplantation International 2006;19 (6):492-9.
25. DeMets 1987 DeMets DL. Methods for combining randomized clinical trials: strengths and limitations. Statistics in Medicine 1987;6(3):341-50.
26. DerSimonian 1986 DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177-88.
27. Egger 1997 Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical Research Ed.) 1997; 315(7109):629-34.
28. Garbino 2005 Garbino J, Romand JA, Pittet D, Giostra E, Mentha G, Suter P. Infection and rejection in liver transplant patients: a 10-year Swiss single-centre experience. Swiss Medical Weekly 2005;135(39-40): 587-93.
29. Gluud 2007 Gluud C, Nikolova D, Klingenberg SL, Als-Nielsen B, D'Amico G, Davidson B, et al.Cochrane Hepato-Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2007, Issue 2. Art. No.: LIVER.
30. Haddad 2006 Haddad EM, McAlister VC, Renouf E, Malthaner R, Kjaer MS, Gluud LL. Cyclosporin versus tacrolimus for liver transplanted patients. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.: CD005161. DOI: 10.1002/14651858.CD005161.pub2.
31. Higgins 2002 Higgins JPT, Thompson SG. Quantifying heterogeneity in a metaanalysis. Statistics in Medicine 2002;21(11):1539-58.
32. Higgins 2006 Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]. The Cochrane Library. Chichester, UK: John Wiley & Sons, Ltd, Issue 4, 2006.
33. Hodson 2005 Hodson EM, Barclay PG, Craig JC, Jones C, Kable K, Strippoli GFM, et al.Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD003774. DOI: 10.1002/14651858.CD003774.pub2.
34. Hull 2004 Hull MW, Beck PL. Clostridium difficile-associated colitis. Canadian Family Physician 2004;50:1536-40, 1543-5.
35. Kamath 2001 Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al.A model to predict survival in patients with endstage liver disease. Hepatology 2001;33(2):464-70.
36. Kato 2005 Kato T, Yoshida H, Sadfar K, Martinez E, Nishida S, Moon J, et al.Steroid-free induction and preemptive antiviral therapy for liver transplant recipients with hepatitis C: a preliminary report from a prospective randomized study. Transplant Proceedings 2005;37(2): 1217-9.
37. Kjaergard 2001 Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials inmetaanalyses. Annals of Internal Medicine 2001;135(11):982-9.
38. Koneru 2005 Koneru B, Fisher A, He Y, Klein KM, Skurnick J, Wilson DJ, et al.Ischemic preconditioning in deceased donor liver transplantation: a prospective randomized clinical trial of safety and efficacy. Liver Transplantation 2005;11(2):196-202.
39. Lim 2006 Lim SG, Wai CT, Da Costa M, Sutedja DS, Lee YM, Lee KH, et al.Referral patterns and waiting times for liver transplantation in Singapore. Singapore Medical Journal 2006;47(7):599-603.
40. Macaskill 2001 Macaskill P, Walter SD, Irwig L. A comparison of methods to detect publication bias in meta-analysis. Statistics in Medicine 2001;20(4): 641-54.
41. Mehrabi 2006 Mehrabi A, Fonouni H, Wente M, Sadeghi M, Eisenbach C, Encke J, et al.Wound complications following kidney and liver transplantation. Clinical Transplantation 2006;20(Suppl 17):97-110.
42. Moher 1998 Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al.Does quality of reports of randomised trials affect estimates of intervention efficacy reported inmeta-analyses?. Lancet 1998;352(9128):609-13.
43. Newell 1992 Newell DJ. Intention-to-treat analysis: implications for quantitative and qualitative research. International Journal of Epidemiology 1992; 21(5):837-41.
44. NHS UK transplant NHS UK Transplant - Annual Report 2003-2004. http://www.uktransplant.org.uk/ukt/about_us/annual_ report/ archive_annual_reports/ann_report_2003_2004.pdf (accessed 22 May 2007).
45. OPTN/SRTR 2005 The Organ Procurement and Transplant Network/ Scientific Registry of Transplant Recipients 2005 Annual Report. http://www.ustransplant.org/annual_reports/current/905_li.pdf (accessed 22 May 2007).
46. Patel 1997 Patel R, Paya CV. Infections in solid-organ transplant recipients. Clinical Microbiology Reviews 1997;10(1):86-124.
47. Playford 2004 Playford EG, Webster AC, Sorell TC, Craig JC. Antifungal agents for preventing fungal infections in solid organ transplant recipients. Cochrane Database of Systematic Reviews 2004, Issue 3. Art. No.: CD004291. DOI: 10.1002/14651858.CD004291.pub2.
48. RevMan 2003 Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 4.2 for Windows. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2003.
49. Royle 2003 Royle P, Milne R. Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches. International Journal of Technology Assessment in Health Care 2003; 19(4):591-603.
50. Safdar 2004 Safdar N, Said A, Lucey MR. The role of selective digestive decontamination for reducing infection in patients undergoing liver transplantation: a systematic review and meta-analysis. Liver Transplantation 2004;10(7):817-27.
51. Schulz 1995 Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408- 12.
52. Shiffman 2006 Shiffman ML, Saab S, Feng S, Abecassis MI, Tzakis AG, Goodrich NP, et al.Liver and intestine transplantation in the United States, 1995-2004. American Journal of Transplantation 2006;6(5 Pt 2): 1170-87.
53. Strippoli 2006 Strippoli GF, Hodson EM, Jones CJ, Craig JC. Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No.: CD005133. DOI: 10.1002/14651858.CD005133.pub2.
54. Sweeting 2004 Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Statistics in Medicine 2004;23(9):1351-75.